AMPK activation inhibits downstream targets fatty acid synthase (FASN) and sterol element regulatory protein (SREBP-1c), regulating hepatic lipid metabolism disorders (64, 65). The gene discussed is SREBF1; the disease is Disorder of lipid metabolism.